GB9711578D0 - Novel retroviral vector production systems - Google Patents

Novel retroviral vector production systems

Info

Publication number
GB9711578D0
GB9711578D0 GBGB9711578.6A GB9711578A GB9711578D0 GB 9711578 D0 GB9711578 D0 GB 9711578D0 GB 9711578 A GB9711578 A GB 9711578A GB 9711578 D0 GB9711578 D0 GB 9711578D0
Authority
GB
United Kingdom
Prior art keywords
retroviral vector
production systems
vector production
novel retroviral
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9711578.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Priority to GBGB9711578.6A priority Critical patent/GB9711578D0/en
Publication of GB9711578D0 publication Critical patent/GB9711578D0/en
Priority to PCT/GB1998/001626 priority patent/WO1998055640A1/fr
Priority to JP50185799A priority patent/JP2002510204A/ja
Priority to CA002289491A priority patent/CA2289491A1/fr
Priority to IL13235998A priority patent/IL132359A0/xx
Priority to KR19997011328A priority patent/KR20010013332A/fr
Priority to AU77800/98A priority patent/AU741764B2/en
Priority to CN98805788A priority patent/CN1259171A/zh
Priority to EP98925826A priority patent/EP0986649A1/fr
Priority to NZ500936A priority patent/NZ500936A/en
Priority to NO995900A priority patent/NO995900L/no
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14144—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB9711578.6A 1997-06-04 1997-06-04 Novel retroviral vector production systems Pending GB9711578D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB9711578.6A GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems
NZ500936A NZ500936A (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system capable of delivering a nucleotide sequence of interest (NOI)
IL13235998A IL132359A0 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
JP50185799A JP2002510204A (ja) 1997-06-04 1998-06-04 バキュロウイルス発現系内で作製されるレトロウイルスベクター粒子
CA002289491A CA2289491A1 (fr) 1997-06-04 1998-06-04 Particules de vecteur de retrovirus produites dans un systeme d'expression de baculovirus
PCT/GB1998/001626 WO1998055640A1 (fr) 1997-06-04 1998-06-04 Particules de vecteur de retrovirus produites dans un systeme d'expression de baculovirus
KR19997011328A KR20010013332A (fr) 1997-06-04 1998-06-04 Particules de vecteur de retrovirus produites dans un systeme d'expression de baculovirus
AU77800/98A AU741764B2 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system
CN98805788A CN1259171A (zh) 1997-06-04 1998-06-04 在杆状病毒表达系统中产生的反转录病毒载体颗粒
EP98925826A EP0986649A1 (fr) 1997-06-04 1998-06-04 Particules de vecteur de retrovirus produites dans un systeme d'expression de baculovirus
NO995900A NO995900L (no) 1997-06-04 1999-12-02 Retrovirale vektorpartikler dannet i et baculovirus- ekspresjonssystem

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711578.6A GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems

Publications (1)

Publication Number Publication Date
GB9711578D0 true GB9711578D0 (en) 1997-07-30

Family

ID=10813571

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9711578.6A Pending GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems

Country Status (11)

Country Link
EP (1) EP0986649A1 (fr)
JP (1) JP2002510204A (fr)
KR (1) KR20010013332A (fr)
CN (1) CN1259171A (fr)
AU (1) AU741764B2 (fr)
CA (1) CA2289491A1 (fr)
GB (1) GB9711578D0 (fr)
IL (1) IL132359A0 (fr)
NO (1) NO995900L (fr)
NZ (1) NZ500936A (fr)
WO (1) WO1998055640A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073424A1 (fr) * 1999-05-28 2000-12-07 Mount Sinai School Of Medicine Nouveau vecteur hybride du baculovirus/adenovirus utile pour la sauvegarde, la production et le titrage des vecteurs d'amplicon d'adenovirus haute capacite
US6870045B2 (en) 2000-10-23 2005-03-22 Gen-Probe Incorporated Kits for detecting HIV-2
US9333249B2 (en) 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
TWI477602B (zh) 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
KR101164602B1 (ko) * 2008-01-09 2012-07-10 주식회사 케이알바이오텍 배큘로바이러스?기반 백신

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001029A1 (fr) * 1987-07-24 1989-02-09 Cetus Corporation Culture de cellules d'insectes portees par l'air
WO1989009271A1 (fr) * 1988-03-21 1989-10-05 Viagene, Inc. Retrovirus recombinants
WO1991019803A1 (fr) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Particules virales autoassemblees defectueuses qui ne se propagent pas d'elles-memes
GB9510272D0 (en) * 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors

Also Published As

Publication number Publication date
JP2002510204A (ja) 2002-04-02
NO995900L (no) 2000-02-04
WO1998055640A1 (fr) 1998-12-10
AU741764B2 (en) 2001-12-06
EP0986649A1 (fr) 2000-03-22
AU7780098A (en) 1998-12-21
NZ500936A (en) 2001-11-30
IL132359A0 (en) 2001-03-19
NO995900D0 (no) 1999-12-02
CN1259171A (zh) 2000-07-05
KR20010013332A (fr) 2001-02-26
CA2289491A1 (fr) 1998-12-10

Similar Documents

Publication Publication Date Title
IL124607A0 (en) Retroviral protease inhibiting compounds
AU6145998A (en) Skeletal plating system
HK1026889A1 (en) Novel aryloxy-alkyl-dialkylamines
AU134766S (en) Zipperless wetsuit
SI1036083T1 (en) Novel 9a-azalides
GB9711124D0 (en) Novel cyanoguanidines
GB9711119D0 (en) Novel cyanoguanidines
EP0986389A4 (fr) Nouveau procede
GB9506782D0 (en) Retroviral vectors
GB9711578D0 (en) Novel retroviral vector production systems
GB9711122D0 (en) Novel cyanoguanidines
GB9711127D0 (en) Novel cyanoguanidines
GB9702218D0 (en) Novel product
GB2345062B (en) Retroviral vectors
AU132858S (en) Wetsuit
GB9711523D0 (en) Structural systems
GB2331752B (en) Vectors
GB9720633D0 (en) BHV-2 vector
GB9624457D0 (en) Retroviral vectors
GB9708269D0 (en) Targeted retroviral vectors
PL322145A1 (en) Shaped structural member
GB9608328D0 (en) Improved retroviral vectors
GB9719593D0 (en) Coating system
GB9702217D0 (en) Novel product
GB9702215D0 (en) Novel product